Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : NEOTHERAPEUTICS (NEOT) (NEOTW) -- Ignore unavailable to you. Want to Upgrade?

To: Lee Fredrickson who wrote (278)	5/16/1998 6:23:00 PM
From: David M. Evans	Respond to of 705

Well, depending on when you made your purchase you should receive an Annual report shortly which details the other drugs in the pipeline. One of the things I like about NEOT is that they have a number of compounds, so you're not wagering it all on one horse ... So they didn't respond to your e-mail? Not surprised, by anything they do in the shareholder/investor relations area anymore ... They are spending money on G&A somewhere - not on IR, obviously ...

To: Lee Fredrickson who wrote (278)	5/17/1998 11:13:00 AM
From: john jansen	Respond to of 705

Lee try their telephone works for me.

To: Lee Fredrickson who wrote (278)	5/18/1998 1:23:00 PM
From: Marty	Read Replies (1) \| Respond to of 705

Try e-mailing chess@neotherapeutics.com I think she is in charge of investor relations. They have been good about responding to requests but I don't know if they check the web site or update it that often. If you get a response about the status of any of the other drugs in the pipeline please share it with the thread. I am pretty excited about the prospects for their drug that addresses spinal cord injuries and would love to know how that stands now. Welcome to the thread.